These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 22691512)
21. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies. O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694 [TBL] [Abstract][Full Text] [Related]
22. 18F-FDG PET scanning in pulmonary amyloidosis. Baqir M; Lowe V; Yi ES; Ryu JH J Nucl Med; 2014 Apr; 55(4):565-8. PubMed ID: 24556593 [TBL] [Abstract][Full Text] [Related]
24. Oncocytic carcinoid tumor of the lung with intense F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography-computed tomography (PET/CT). Tanabe Y; Sugawara Y; Nishimura R; Hosokawa K; Kajihara M; Shimizu T; Takahashi T; Sakai S; Sawada S; Yamashita M; Ohtani H Ann Nucl Med; 2013 Oct; 27(8):781-5. PubMed ID: 23757317 [TBL] [Abstract][Full Text] [Related]
25. Targeted lymph node biopsy in mediastinoscopy using 3D FDG-PET/CT movies: a feasibility study. Siepel FJ; de Bruin WI; van Duyn EB; Steenvoorde P; Wagenaar NR; Slump CH; van Dalen JA Nucl Med Commun; 2012 Apr; 33(4):439-44. PubMed ID: 22311052 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data. Vural GU; Akkas BE; Ercakmak N; Basu S; Alavi A Clin Nucl Med; 2012 Oct; 37(10):953-9. PubMed ID: 22899202 [TBL] [Abstract][Full Text] [Related]
27. Malignant disease as an incidental finding at ¹⁸F-FDG-PET/CT scanning in patients with granulomatous lung disease. Huber H; Hodolic M; Stelzmüller I; Wunn R; Hatzl M; Fellner F; Lamprecht B; Rubello D; Colletti PM; Gabriel M Nucl Med Commun; 2015 May; 36(5):430-7. PubMed ID: 25646704 [TBL] [Abstract][Full Text] [Related]
28. Usefulness of (18)F-FDG PET/CT in a rare case of malignant pseudothyroiditis. Treglia G; Del Ciello A; Fadda G; Calcagni ML Clin Nucl Med; 2014 Feb; 39(2):e163-5. PubMed ID: 23531733 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
31. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility. Basu S; Li G; Bural G; Alavi A Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692 [TBL] [Abstract][Full Text] [Related]
32. Metastatic lung nodule diagnosed on 18F-FDG PET/CT-guided fine needle aspiration in a patient with renal cell carcinoma. Manohar K; Bhattacharya A; Vyas S; Dey P; Mandal AK; Abrar ML; Mittal BR Clin Nucl Med; 2013 Jan; 38(1):e38-9. PubMed ID: 23242063 [TBL] [Abstract][Full Text] [Related]
33. Superscan-like hypermetabolic lesions on delayed FDG PET/CT imaging in a patient with lung cancer. Cheng G; Alavi A; Lim E; Akers SR Clin Nucl Med; 2012 Sep; 37(9):912-3. PubMed ID: 22889790 [TBL] [Abstract][Full Text] [Related]
34. A case of pulmonary choriocarcinoma metastasis with unusual FDG-PET and CT findings: correlation with pathology. Maruoka Y; Abe K; Baba S; Isoda T; Matsuo Y; Kubo Y; Ogawa S; Yano T; Sasaki M; Honda H Ann Nucl Med; 2012 Dec; 26(10):835-9. PubMed ID: 22893003 [TBL] [Abstract][Full Text] [Related]
35. A case of giant cell tumor of sacrum with unusual pulmonary metastases: CT and FDG PET findings. Zhang Y; Reeve IP; Lewis DH Clin Nucl Med; 2012 Sep; 37(9):920-1. PubMed ID: 22889794 [TBL] [Abstract][Full Text] [Related]
36. Lymphoepithelioma-like carcinoma of the lung: a rare case report and review of the literature. Fırıncıoğluları A; Akıncı Özyürek B; Erdoğan Y; İncekara F; Yılmaz E; Özaydın HE Tuberk Toraks; 2020 Dec; 68(4):453-457. PubMed ID: 33448744 [TBL] [Abstract][Full Text] [Related]
37. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography. Bar-Shalom R; Kagna O; Israel O; Guralnik L Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145 [TBL] [Abstract][Full Text] [Related]
38. Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature. Treglia G; Calcagni ML; Rufini V; Leccisotti L; Meduri GM; Spitilli MG; Dambra DP; De Gaetano AM; Giordano A Colorectal Dis; 2012 Feb; 14(2):174-80. PubMed ID: 21689289 [TBL] [Abstract][Full Text] [Related]
39. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses. Dennis K; Hay JH; Wilson DC Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464 [TBL] [Abstract][Full Text] [Related]
40. Performance of FDG PET/ceCT in the evaluation of patients with lung cancer. Nanni C; Rossetti V; Zompatori M; Ambrosini V; Montesi V; Mascherini D; Pettinato C; Marzola MC; Colletti PM; Rubello D; Fanti S Biomed Pharmacother; 2014 Mar; 68(2):219-23. PubMed ID: 24486108 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]